Treatment of migraine | Patent Publication Number 20230330072

US 20230330072 A1
Patent NumberUS 11857542 B2
Application Number18210719
Filled DateJun 16, 2023
Priority DateDec 22, 2020
Publication DateOct 19, 2023
Original AssigneeAbbvie Inc.
Current AssigneeAllergan Pharmaceuticals International
Inventor/ApplicantsRamesh Boinpally
Abhijeet Jakate
Michelle Finnegan
Joel M. Trugman
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.